Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults - PubMed (original) (raw)
Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults
Sihoon Lee et al. J Korean Med Sci. 2006 Aug.
Abstract
We investigated the cutoff values of surrogate of insulin resistance for diagnosing metabolic syndrome in Korean adults. The data from 976 non-diabetic individuals (484 men and 492 women) aged 30-79 yr were analyzed. We determined the odds ratios for the prevalence of metabolic syndrome according to the quartiles of fasting insulin, homeostasis model for insulin resistance (HOMA-IR), and quantitative insulin sensitivity check index (QUICKI) as independent variables, while adjusting for age, sex, and body mass index. The cutoff values of fasting insulin, HOMA-IR, and QUICKI were estimated by the areas under the receiver-operating characteristic (ROC) curves. The cutoff points for defining insulin resistance are a fasting insulin level of 12.94 microU/mL, HOMA-IR=3.04 as the 75th percentile value, and QUICKI=0.32 as the 25th percentile value. Compared with the lowest quartile, the adjusted odds ratios for the prevalence of metabolic syndrome in the highest quartiles of fasting insulin, HOMA-IR, and QUICKI were 1.95 (1.26-3.01), 2.27 (1.45-3.56), and 2.27 (1.45-3.56), respectively. The respective cutoff values for fasting serum insulin, HOMA-IR, and QUIC-KI by ROC analysis were 10.57 microU/mL (sensitivity 58.5%, specificity 66.8%), 2.34 (sensitivity 62.8%, specificity 65.7%), and 0.33 (sensitivity 61.2%, specificity 66.8%). Fasting insulin, HOMA-IR, and QUICKI can be used as surrogate measures of insulin resistance in Korean non-diabetic adults.
Figures
Fig. 1
Distribution of age, body mass index, fasting glucose and fasting insulin of study subjects.
Fig. 2
Receiver-operating characteristic (ROC) curves for fasting serum insulin, HOMA-IR, and QUICKI for increased metabolic syndrome. The cutoff values for fasting serum insulin, HOMA-IR, and QUICKI are 10.57 µU/mL (sensitivity 58.5%, specificity 66.8 %), 2.34 (sensitivity 62.8%, specificity 65.7%), and 0.33 (sensitivity 61.2%, specificity 66.8%) (p<0.001, respectively). The areas under the ROC curves (95% CI) for the parameters are 0.656 (0.625-0.685), 0.672 (0.641-0.701), and 0.671 (0.641-0.701), respectively.
References
- Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607. - PubMed
- Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO Consultation. Diabet Med. 1998;15:539–553. - PubMed
- Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA. 2001;285:2486–2497. - PubMed
- Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992;340:925–929. - PubMed
- Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952–957. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical